祥生医疗：10月23日召开董事会会议

Group 1 - The core point of the article is that Xiangsheng Medical (SH 688358) announced the convening of its 16th board meeting on October 23, 2025, to review the proposal for adjusting the grant price of the 2024 restricted stock incentive plan [1] - For the year 2024, Xiangsheng Medical's revenue composition is heavily weighted towards the medical device industry, accounting for 99.88%, while other businesses contribute only 0.12% [1] - As of the report, Xiangsheng Medical has a market capitalization of 3.8 billion yuan [1]